v3.26.1
Schedule of Segment Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]            
Revenue $ 24,245       $ 42,897  
Cost of goods sold 3,181     7,543
Research and development 600,353   759,448   1,011,402 1,226,193
Selling, general and administrative 2,163,656       3,729,897  
Segment net loss (2,742,945)       (4,705,945)  
Other interest income (expense), net 468,548   11,915   369,590 21,051
Net operating loss (2,274,397) $ (2,061,958) $ (2,252,965) $ (1,528,867) (4,336,355) $ (3,781,832)
Reportable Geographical Components [Member]            
Segment Reporting [Line Items]            
Revenue 24,245       42,897  
Cost of goods sold 3,181       7,543  
Research and development 600,353       1,011,402  
Selling, general and administrative 889,868       1,562,057  
Segment net loss (1,469,157)       (2,538,105)  
Other interest income (expense), net        
Net operating loss (1,469,157)       (2,538,105)  
Pharmaceutical Operations [Member] | Reportable Geographical Components [Member]            
Segment Reporting [Line Items]            
Revenue        
Cost of goods sold        
Research and development 600,353       1,011,402  
Selling, general and administrative 503,223       705,531  
Segment net loss (1,103,576)       (1,716,933)  
Other interest income (expense), net        
Net operating loss (1,103,576)       (1,716,933)  
Premium Nutritional Supplements [Member] | Reportable Geographical Components [Member]            
Segment Reporting [Line Items]            
Revenue 24,245       42,897  
Cost of goods sold 3,181       7,543  
Research and development        
Selling, general and administrative 386,645       856,526  
Segment net loss (365,581)       (821,172)  
Other interest income (expense), net        
Net operating loss (365,581)       (821,172)  
Corporate Segment and Other Operating Segment [Member] | Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]            
Segment Reporting [Line Items]            
Revenue        
Cost of goods sold        
Research and development        
Selling, general and administrative 1,273,788       2,167,840  
Segment net loss (1,273,788)       (2,167,840)  
Other interest income (expense), net 468,548       369,590  
Net operating loss $ (805,240)       $ (1,798,250)